Thyroid News

CHICAGO — Commercial insurer payments for teprotumumab vary dramatically, with cost influencing access to care and cost-effectiveness, according to a study presented at the ASOPRS Fall Scientific Symposium.

An increase in cases of subacute thyroiditis in South Korea was observed during the first year of the COVID-19 pandemic, according to a study published in Thyroid.

Most adults with hypoparathyroidism had normalized calcium levels without needing a supplement after 3 months of taking a parathyroid hormone-1 receptor agonist, according to findings from phase 2a trial.

Adolescents with subclinical hypothyroidism do not have an increased risk for major depressive disorder compared with those with normal thyroid function, according to a study published in Thyroid.

CHICAGO — Patients who received Tepezza to treat thyroid eye disease showed improved extraocular muscle size that correlated to improved diplopia and motility, according to a presenter here.

CHICAGO — Pretreatment evaluation of fat-to-muscle ratio in thyroid eye disease will allow for the best treatment choice, a presenter here said.

CHICAGO — Since its approval in 2020, Tepezza has become a go-to treatment for moderate to severe thyroid eye disease, unseating orbital decompression as the most used treatment, according to a presenter here.

CHICAGO — Ophthalmologists should monitor patients with thyroid eye disease when they receive their COVID-19 vaccinations, according to a small case study presented at the ASOPRS Fall Scientific Symposium.

In an afternoon Middle Clinical Experience teaching session, in the fall of 2018, I was sitting in the corner of the exam room watching the two students interviewing the simulated patient.

Active surveillance of newly diagnosed thyroid cancer appeared to be a viable alternative to surgery for certain patients with low-risk disease, results of a prospective trial published in JAMA Oncology showed